Home

Cognition

Depression, Alzheimer's Disease

Read time: 3 min

Global planning and local action: complementary strategies to tackle dementia

From the corridors of the WHO in Geneva to the shopping malls of Singapore, efforts are being made...

Bipolar, Schizophrenia

Read time: 3 min

Could therapeutic manipulation of critical periods of brain development benefit mental health?

Many critical periods of brain development occur during infancy and childhood. When these periods...

Read time: 4 min

Improving long-term outcomes in schizophrenia — translating evidence into practice

The long-term goals of treatment to optimize outcomes for patients with schizophrenia are relapse...

Read time: 5 min

Managing the burdens of bipolar disorder

The cognitive and physiological burdens of bipolar disorder, and some approaches to its treatment,...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Active immunotherapy targets early stage Alzheimer’s disease

Active immunotherapies have been designed to activate an immune response in the human body of...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Initial promise of immunotherapeutics targeting amyloid-β strengthens the possibility of early intervention in Alzheimer’s disease

Clinical studies of immunotherapies show initial promise for early intervention in Alzheimer’...

Alzheimer's Disease

Read time: 3 min

Congress highlights

It’s in the blood – identification of plasma biomarkers brings hope for screening and early detection of Alzheimer’s disease

The recent discovery and validation of blood biomarkers offers huge potential for the early...

Read time: 3 min

Congress highlights

Treating cognitive symptoms improves workplace productivity

The new paradigm for the treatment of major depressive disorder (MDD) is to “make patients...

Read time: 4 min

Congress highlights

Functional recovery in depression: are we doing the right thing for the treatment of depression?

Major depressive disorder (MDD) is a heterogeneous disease characterized by many different mood,...

Bipolar, Schizophrenia

Read time: 4 min

Controversial issues in the management of schizophrenia

Controversial issues in the management of schizophrenia — brain shrinkage, dopamine...

Read time: 5 min

Improving cognition and motivation in schizophrenia to address patient’s goal of restoring social functioning

In schizophrenia, a patient’s goal of ‘personal recovery’ may be different from...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Aging, amyloid and Alzheimer’s Disease

Amyloid-beta (Aβ) burden in cognitively normal older adults increases with age and appears to be...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country